Can endocan be a new biomarker in ventilator-associated pneumonia?
Ventilator-Associated Pneumonia (VAP) is a hospital-acquired bacterial infection with high incidence and mortality rate. The aim of this study is to investigate the correlation between the Endocan level and development of VAP and whether or not this correlation was correlated with the clinical findi...
Main Authors: | Ilke Kupeli, Sara Salcan, Mehmet Kuzucu, Ufuk Kuyrukluyıldız |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-12-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X18301608 |
Similar Items
-
Serum endocan role in diagnosis and prognosis of ventilator associated pneumonia
by: Ashraf Abd El Halim, et al.
Published: (2015-10-01) -
A therapeutic biomarker endocan in infective endocarditis
by: T. Kitazawa, et al.
Published: (2020-12-01) -
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
by: Nathalie De Freitas Caires, et al.
Published: (2018-10-01) -
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
by: Hande Erman, et al.
Published: (2020-01-01) -
Is endocan a novel potential biomarker of liver steatosis and fibrosis?
by: Klisić Aleksandra, et al.
Published: (2020-01-01)